AlTi Global’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
AlTi Global's MRNA Position: Q2 2026 in Review
AlTi Global reduced its Moderna (MRNA) stake by 7.4% in Q2 2026, selling an estimated $16.1K and leaving 3,909 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #444.
AlTi Global first reported a position in MRNA in Q4 2023 and has held it in 5 quarters since. The position peaked at $331K in Q2 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- AlTi Global held 3,909 shares of Moderna worth $274K as of Q2 2026.
- AlTi Global sold 311 Moderna shares in Q2 2026, an estimated $16.1K.
- Moderna made up 0.01% of AlTi Global's portfolio in Q2 2026, its #444 holding.
- AlTi Global first reported a position in Moderna in Q4 2023 and has held it in 5 quarters since.
- AlTi Global's Moderna position peaked at $331K in Q2 2024.
- 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.